These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 15122206)

  • 1. The proteasome: a suitable antineoplastic target.
    Adams J
    Nat Rev Cancer; 2004 May; 4(5):349-60. PubMed ID: 15122206
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecule of the month. Bortezomib.
    Drug News Perspect; 2003 Jun; 16(5):324. PubMed ID: 12942163
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proteasome inhibitor, bortezomib (Vercade), potently inhibits the growth of adult T-cell leukemia cells].
    Satou Y; Matsuoka M
    Nihon Rinsho; 2004 Jul; 62(7):1363-7. PubMed ID: 15283157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proteolysis and cell cycle regulation].
    Tsurumi C; Tanaka K
    Tanpakushitsu Kakusan Koso; 1996 Sep; 41(12 Suppl):1813-9. PubMed ID: 8890641
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting proteasome inhibition in hematologic malignancies.
    Hideshima T; Richardson PG; Anderson KC
    Rev Clin Exp Hematol; 2003 Jun; 7(2):191-204. PubMed ID: 14763162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting proteasomes: trash to treasure.
    Sussman HE
    Drug Discov Today; 2003 Oct; 8(19):866-8. PubMed ID: 14554007
    [No Abstract]   [Full Text] [Related]  

  • 7. Gamma-secretase: proteasome of the membrane?
    Kopan R; Ilagan MX
    Nat Rev Mol Cell Biol; 2004 Jun; 5(6):499-504. PubMed ID: 15173829
    [No Abstract]   [Full Text] [Related]  

  • 8. Roles of the proteasome in neurodegenerative disease: refining the hypothesis.
    Cookson MR
    Ann Neurol; 2004 Sep; 56(3):315-6. PubMed ID: 15349856
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.
    Papandreou CN; Daliani DD; Nix D; Yang H; Madden T; Wang X; Pien CS; Millikan RE; Tu SM; Pagliaro L; Kim J; Adams J; Elliott P; Esseltine D; Petrusich A; Dieringer P; Perez C; Logothetis CJ
    J Clin Oncol; 2004 Jun; 22(11):2108-21. PubMed ID: 15169797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p27KIP1: androgen regulation and prognostic significance in prostate cancer.
    Loda M
    Adv Clin Path; 2000 Oct; 4(4):226-32. PubMed ID: 11436163
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteasome inhibition: a novel approach to cancer therapy.
    Adams J
    Trends Mol Med; 2002; 8(4 Suppl):S49-54. PubMed ID: 11927288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteasome inhibitors].
    Hatake K; Mishima Y; Terui Y
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):999-1002. PubMed ID: 15272575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome inhibitors as new anticancer drugs.
    Adams J
    Curr Opin Oncol; 2002 Nov; 14(6):628-34. PubMed ID: 12409653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Signal transduction of wound responses in plants].
    Seo S; Ito N; Ohashi Y
    Tanpakushitsu Kakusan Koso; 1999 Nov; 44(15 Suppl):2347-52. PubMed ID: 10586680
    [No Abstract]   [Full Text] [Related]  

  • 15. Proteasomes and their kin: proteases in the machine age.
    Pickart CM; Cohen RE
    Nat Rev Mol Cell Biol; 2004 Mar; 5(3):177-87. PubMed ID: 14990998
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and enrichment of proteolytic enzymes of IL-2 activated rat natural killer (A-NK) cells: potential physiological roles in NK cell function.
    Kitson RP; Wasserman K; Goldfarb RH
    Immunol Ser; 1994; 61():83-92. PubMed ID: 8011759
    [No Abstract]   [Full Text] [Related]  

  • 17. MYC-induced sensitivity of human malignant melanoma to proteasome inhibitors - a KaMYCaze effect.
    Fuchs SY
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):9-10. PubMed ID: 18353138
    [No Abstract]   [Full Text] [Related]  

  • 18. Assays for proteasome inhibition.
    Elliott PJ; Soucy TA; Pien CS; Adams J; Lightcap ES
    Methods Mol Med; 2003; 85():163-72. PubMed ID: 12710207
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of human chronic lymphocytic leukemia cells with the proteasome inhibitor bortezomib promotes apoptosis.
    Kelley TW; Alkan S; Srkalovic G; Hsi ED
    Leuk Res; 2004 Aug; 28(8):845-50. PubMed ID: 15203282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib as a potential treatment for prostate cancer.
    Papandreou CN; Logothetis CJ
    Cancer Res; 2004 Aug; 64(15):5036-43. PubMed ID: 15289299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.